Document Detail


Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
MedLine Citation:
PMID:  17517444     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The response of tumours to fractionated radiotherapy is determined by many factors including repopulation, reoxygenation, the number of clonogenic cells, and their intrinsic radiosensitivity. However, after single radiation doses given under conditions of clamp hypoxia, the dose to control a tumour locally is dependent only on the number of clonogenic cells and their cellular radiosensitivity. Therefore, these parameters were investigated using local control after single doses given under hypoxia, to predict the outcome of fractionated irradiation. MATERIALS AND METHODS: Ten hSCC cell lines (FaDu, UT-SCC-15, UT-SCC-14, XF354, UT-SCC-5, UT-SCC-45, SAS, CAL-33, UT-SCC-8, and HSC-4) were transplanted subcutaneously into the right hind-leg of NMRI nude mice. At 7mm in diameter, tumours were irradiated either with graded single doses under clamp blood flow conditions (n=873) or with 30 graded fractions within 6 weeks (n=905) under ambient conditions. Local tumour control was determined 120 days after irradiation. Radiation response was quantified in terms of TCD(50), i.e. the dose required to control 50% of tumours locally. RESULTS: Ten tumour lines investigated showed a pronounced heterogeneity in both TCD(50(30fx/6w)) after fractionated irradiation and TCD(50(SDclamp)) after single dose irradiation. TCD(50(30fx/6w)) varied between 45Gy for UT-SCC-45 and 127Gy for SAS; TCD(50(SDclamp)) varied between 42Gy for UT-SCC-14 and 66Gy for CAL-33. Two tumours were excluded from further analysis due to immunogenicity or non-defined TCD(50). Linear regression analysis revealed a significant positive correlation between TCD(50(SDclamp)) and TCD(50(30fx/6w)) (R(2)=0.82, p=0.002). CONCLUSIONS: Significant association between TCD(50(SDclamp)) and TCD(50(30fx/6w)) suggests that the pre-treatment number of clonogenic tumour cells and their cellular radiosensitivity have a major impact on local control after fractionated radiotherapy.
Authors:
Ala Yaromina; Marie Krause; Howard Thames; Andrea Rosner; Mechthild Krause; Franziska Hessel; Reidar Grenman; Daniel Zips; Michael Baumann
Related Documents :
17214344 - Parathyroid cancer: etiology, clinical presentation and treatment.
8024504 - Treatment of early carcinoma of the vocal cords by radiotherapy.
6253864 - Mucinous colorectal carcinoma: immunopathology and prognosis.
11142484 - Improved effect of 131i-mibg treatment by predosing with non-radiolabeled mibg in carci...
1664154 - Daily low-dose carboplatin and standard radiotherapy in unresectable head and neck and ...
22521504 - Pilot study of denileukin diftitox alternate dosing regimen in patients with cutaneous ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-05-22
Journal Detail:
Title:  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology     Volume:  83     ISSN:  0167-8140     ISO Abbreviation:  Radiother Oncol     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-06-20     Completed Date:  2008-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8407192     Medline TA:  Radiother Oncol     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  304-10     Citation Subset:  IM    
Affiliation:
OncoRay - Centre for Radiation Research in Oncology, University of Technology Dresden, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carcinoma, Squamous Cell / radiotherapy*
Cell Count
Cell Hypoxia
Clone Cells / radiation effects*
Dose Fractionation*
Dose-Response Relationship, Radiation
Female
Head and Neck Neoplasms / radiotherapy*
Humans
Male
Mice
Mice, Nude
Neoplasm Recurrence, Local / prevention & control*
Radiation Tolerance*
Tumor Stem Cell Assay
Xenograft Model Antitumor Assays

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A model (BSurvE) for evaluating national surveillance programs for bovine spongiform encephalopathy.
Next Document:  Extent of satisfaction with tablets and food-timing in sulphonylurea-treated diabetes.